FEATURED/ARCHIVES (04/05/24)
Specific Genes Associated with Adverse Events of Methylphenidate Use in the Pediatric Population: A Systematic Literature Review · May 2017
Articles
Journal of Research in Pharmacy Practice
Lithium’s Antiviral Effects: A Potential Drug for CoViD-19 Disease? · May 2020
Articles
International Journal of Bipolar Disorders
Long-Term Effectiveness of Aripiprazole Once-Monthly for Schizophrenia Is Maintained in the QUALIFY Extension Study · April 2017
Articles
Schizophrenia Research
Effects of Escitalopram in Prevention of Depression in Patients with Acute Coronary Syndrome (DECARD) · September 2011
Abstracts
Journal of Psychosomatic Research
Adjunctive Brexpiprazole for Elderly Patients with Major Depressive Disorder: An Open-Label, Long-Term Safety and Tolerability Study · July 2018
Articles
International Journal of Geriatric Psychiatry
Inflammation and Depression: Combined Use of Selective Serotonin Reuptake Inhibitors and NSAIDs or Paracetamol and Psychiatric Outcomes · May 2015
Articles
Brain and Behavior
Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder: A Phase 3, Randomized, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants · September 2015
Abstracts
Journal of Clinical Psychiatry
Smoking Cessation with Four Nicotine Replacement Regimes in a Lung Clinic · October 2000
Articles
European Respiratory Journal
Intravenous Vortioxetine to Accelerate Onset of Effect in Major Depressive Disorder: A 7-Day Randomized, Double-Blind, Placebo-Controlled Exploratory Study · November 2020
Articles
International Clinical Psychopharmacology
Suicidal Ideation During Treatment of Depression with Escitalopram and Nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): A Clinical Trial · October 2009
Articles
BMC Medicine
Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial · December 2013
Articles
Advances in Therapy
Long-Term Safety of a Weekly and Monthly Subcutaneous Buprenorphine Depot (CAM2038) in the Treatment of Adult Out-Patients with Opioid Use Disorder · April 2019
Articles
Addiction
Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with Inadequate Response to SSRI/SNRI Treatment · March 2021
Articles
Journal of Affective Disorders
Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients · March 2017
Articles
Journal of Child and Adolescent Psychopharmacology
Considering Benefits and Harms of Duloxetine for Treatment of Stress Urinary Incontinence: A Meta-Analysis of Clinical Study Reports · February 2017
Articles
Canadian Medical Association Journal
Phenobarbital Compared to Benzodiazepines in Alcohol Withdrawal Treatment: A Register-Based Cohort Study of Subsequent Benzodiazepine Use, Alcohol Recidivism and Mortality · February 2016
Abstracts
Drug and Alcohol Dependence
Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial · September 2015
Articles
American Journal of Psychiatry
The Safety and Tolerability of Aripiprazole Once-Monthly as Maintenance Treatment for Bipolar I Disorder: A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study · July 2018
Articles
Journal of Affective Disorders
Changes in Metabolic Parameters and Body Weight in Brexpiprazole-Treated Patients with Acute Schizophrenia: Pooled Analyses of Phase 3 Clinical Studies · July 2018
Abstracts
Current Medical Research and Opinion